Hyperplasia of pancreatic duct epithelium produced by exposure to sodium deoxycholate.
Severe epithelial hyperplasia was produced in a canine model by the perfusion of the main pancreatic duct with 15 mM of deoxycholate at rates as low as 1.5 ml/day in 6 to 14 days. At higher rates (5 ml/day) deoxycholate caused complete epithelial cell lysis in the duct closest to the tip of the cannula with hyperplastic changes downstream from this section. Perfusion with a buffer solution alone and cannulation alone produced none of these changes in similar duct segments. No hyperplasia was seen in the upstream cannula obstructed duct, even in the presence of severe atrophy. Long-term (81 days) perfusion with 3 mM of deoxycholate at 3 ml/day resulted in more severe hyperplasia that still appeared benign. When glycine-conjugated deoxycholate was perfused through the duct, hyperplasia but no cell lysis was seen. In vitro, deoxycholate caused epithelial cell lysis in pancreatic duct fragments at concentrations of 0.5 mM and above. The results of this study suggest that secondary bile salts or other similar surface-active cytotoxic agents present in the biliary tree or duodenum may play a more important role in the pathogenesis of pancreatic ductal epithelial hyperplasia associated with pancreatic cancer than ductal obstruction.
D000818:Animals; D001655:Bile Reflux / Q000150:complications; D003840:Deoxycholic Acid / Q000378:metabolism / Q000633:toxicity*; D004285:Dogs; D004848:Epithelium / Q000473:pathology; D006965:Hyperplasia; D066298:In Vitro Techniques; D010183:Pancreatic Ducts / Q000473:pathology*
D003840:Deoxycholic Acid